# DEARhealth

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dearhealth

- Industry: Software
- Headquarters: Santa Monica, US
- Website: www.dearhealth.com
- Total disclosed funding: $6.7M
- Latest round: Series A (Jul 18, 2019)
- Investors on record: 4

## About

DEARhealth, Inc. develops innovative software solutions designed for healthcare providers, focusing on personalized patient care through dynamic decision support and risk management pathways.DEARhealth, Inc. specializes in software as a medical device, improving patient management with intelligent care pathways. Founded in Santa Monica, US, the company has undergone strategic developments that have enhanced its service delivery. The current CEO, C Houck, leads the company as it continues to operate independently. In July 2019, DEARhealth raised EUR 6 million in Series A funding from investors including Health Innovations, Philips Venture Capital, and Vesalius Biocapital, constituting the total amount raised.DEARhealth's core product offering is a software as a medical device that utilizes dynamic and risk-based care pathways along with intelligent decision support recommendations. This system continuously monitors patient information to facilitate timely interventions, aiming to guide each patient to the lowest possible risk level. By personalizing healthcare based on real-time patient needs, DEARhealth enhances the quality of life for users while supporting their daily activities and productivity. The platform is designed to standardize care pathways, which allows healthcare providers to manage an increasing patient load effectively by optimizing care delivery. DEARhealth's solutions serve a diverse clientele, including hospitals and healthcare providers primarily in the Netherlands, but also extend to various leading healthcare institutions worldwide.DEARhealth generates revenue through a subscription-based model, providing access to its software platform for healthcare providers and institutions. Clients typically enter into partnerships where they utilize the software for patient management and care pathway optimization. This transactional structure allows healthcare organizations to benefit from enhanced patient outcomes while also achieving cost efficiencies, such as reduced hospital visits and lower overall treatment costs. The pricing plans for the software are structured to reflect the scale and needs of the healthcare institutions, which can vary based on the number of users and the specific features required. By focusing on B2B transactions, DEARhealth positions its services to primarily serve healthcare providers seeking to improve operational efficiency and patient care delivery.Following its Series A funding in July 2019, DEARhealth plans to enhance its software offerings and explore opportunities for expansion into new markets. The company is targeting regions beyond the Netherlands, aiming to introduce its solutions to additional European healthcare systems by 2024. The EUR 6 million raised will facilitate the development of new products and the scaling of operations to meet the growing demand for effective healthcare management solutions.

## Funding rounds

- Series A, Jul 18, 2019, $6.7M — Vesalius Biocapital, Health Innovations, Philips Health Technology Ventures
- Seed, Aug 1, 2017 — Kairos Ventures

## Investors

- Kairos Ventures (https://capitalatlas.ai/funds/kairos-ventures) — Seed
- Vesalius Biocapital (https://capitalatlas.ai/funds/vesalius-biocapital) — Series A
- Health Innovations (https://capitalatlas.ai/funds/health-innovations) — Series A
- Philips Health Technology Ventures (https://capitalatlas.ai/funds/philips-health-technology-ventures) — Series A